DREAMSPHEN: a randomised controlled study comparing dose reduction of antipsychotics vs maintenance treatment in schizophrenia spectrum disorder after stratification based on patients' psychotic phenotype - study protocol of a personalised medicine approach. [PDF]
Berna F +4 more
europepmc +1 more source
Exploring early intervention in psychosis (EIP) perspectives towards pharmacogenomics (PGx) implementation to support antipsychotic prescribing: a multi-method qualitative exploration. [PDF]
Jameson A +7 more
europepmc +1 more source
Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia. [PDF]
Twumasi R +6 more
europepmc +1 more source
A prospective cross-sectional study on pharmacovigilance of antipsychotic drugs at a tertiary care teaching hospital. [PDF]
Jain P, Marko S, Dubey L, Gupta P.
europepmc +1 more source
Prevalence of antipsychotic polypharmacy in patients with schizophrenia and other psychotic disorders in the MENAT and EMRO countries: a systematic review and meta-analysis. [PDF]
Alhassan MA +7 more
europepmc +1 more source
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review. [PDF]
Okon-Rocha E, Taylor D.
europepmc +1 more source
Adherence to ECG Monitoring Before Initiating Antipsychotics in Psychiatric Inpatients at Sultan Qaboos University Hospital: A Clinical Audit. [PDF]
Al Harrasi A, Al Difai Z.
europepmc +1 more source
Social and Clinical Factors Associated With Antipsychotic Medication Discontinuation in Patients With Schizophrenia. [PDF]
Chen Z +7 more
europepmc +1 more source
Non-pharmacological interventions for antipsychotic drug-related metabolic abnormalities: a systematic narrative review. [PDF]
Liu J +7 more
europepmc +1 more source
Trends in the Use of Atypical Antipsychotics Among Children and Adolescents With Bipolar Spectrum Disorders in Korea. [PDF]
Park KJ, Kim YJ, Jung E, Kim JY, Kim HW.
europepmc +1 more source

